Norcross, Ga.-based RayBiotech has launched a partnering program to provide its proteomic analysis services through diagnostic core facilities at academic and government research institutes in the US and Canada.

The company aims to emphasize its Quantibody biomarker quantitation tools, but all of its services, including ELISAs and phosphorylation arrays, will be available through the program.

The initiative is focused on core facilities that emphasize protein biomarker and proteomic analyses in their offerings to researchers, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.